Digital health for patients with multiple myeloma: an unmet need
Multiple myeloma (MM) is associated with the highest symptom burden and lowest health-
related quality of life (HRQoL) among patients with hematologic malignancies. HRQoL in …
related quality of life (HRQoL) among patients with hematologic malignancies. HRQoL in …
[HTML][HTML] Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry
CH Blimark, I Turesson, A Genell, L Ahlberg… - …, 2018 - ncbi.nlm.nih.gov
Epidemiology and outcome of myeloma are mainly reported from large university centers
and collaborative groups, and do not represent 'real-world'patients. The Swedish Myeloma …
and collaborative groups, and do not represent 'real-world'patients. The Swedish Myeloma …
[HTML][HTML] Socioeconomic status is globally a prognostic factor for overall survival of multiple myeloma patients: synthesis of studies and review of the literature
S Intzes, M Symeonidou, K Zagoridis… - … of Hematology and …, 2021 - ncbi.nlm.nih.gov
Background Socioeconomic status (SES) is reflecting differences in sociodemographic
factors affecting cancer survivorship. Deprived, low SES populations have a higher …
factors affecting cancer survivorship. Deprived, low SES populations have a higher …
Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database
P Zhu, XL Du, JJ Zhu, Y Esquenazi - Journal of neurosurgery, 2019 - thejns.org
OBJECTIVE The present study was designed to explore the association between facility type
(academic center [AC] vs non-AC), facility volume (high-volume facility [HVF] vs low-volume …
(academic center [AC] vs non-AC), facility volume (high-volume facility [HVF] vs low-volume …
[HTML][HTML] Socioeconomic factors and survival of multiple myeloma patients
Simple Summary Multiple Myeloma is the third most common hematologic malignancy.
Outcomes have improved significantly, as the result of the introduction of novel agents as …
Outcomes have improved significantly, as the result of the introduction of novel agents as …
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: a comprehensive look at racial disparities
S Ailawadhi, RD Frank, M Sharma, R Menghani… - Cancer, 2018 - Wiley Online Library
BACKGROUND Outcomes have improved significantly in multiple myeloma (MM), but racial
disparities in health care access and survival exist. A comprehensive analysis exploring MM …
disparities in health care access and survival exist. A comprehensive analysis exploring MM …
Association between treatment at high-volume facilities and improved overall survival in soft tissue sarcomas
Purpose Soft tissue sarcomas (STS) are rare malignancies that require complex
multidisciplinary management. Therefore, facilities with high sarcoma case volume may …
multidisciplinary management. Therefore, facilities with high sarcoma case volume may …
Treatment facility volume and survival in patients with metastatic renal cell carcinoma: a registry-based analysis
SS Joshi, EA Handorf, M Zibelman, ER Plimack… - European urology, 2018 - Elsevier
Background Higher treatment facility (TF) volume has been linked with improved oncologic
treatment outcomes. Objective To determine the association between TF volume and overall …
treatment outcomes. Objective To determine the association between TF volume and overall …
Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma
Objective To identify if facility type and/or facility volume impact overall survival (OS)
following diagnosis of glioblastoma (GBM). We also sought to compare early post-surgical …
following diagnosis of glioblastoma (GBM). We also sought to compare early post-surgical …
[HTML][HTML] Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey
P Bories, S Lamy, C Simand, S Bertoli, C Delpierre… - …, 2018 - ncbi.nlm.nih.gov
Elderly patients with acute myeloid leukemia can be treated with intensive chemotherapy,
low-intensity therapy such as low-dose aracytine or hypomethylating agents, or best …
low-intensity therapy such as low-dose aracytine or hypomethylating agents, or best …